Overlap in drug-disease associations between clinical practice guidelines and drug structured product label indications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1480
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Overlap in drug-disease associations between clinical practice guidelines and drug structured product label indications ; volume:7 ; number:1 ; day:8 ; month:6 ; year:2016 ; pages:1-10 ; date:12.2016
Journal of biomedical semantics ; 7, Heft 1 (8.6.2016), 1-10, 12.2016
- Creator
-
Leung, Tiffany I.
- Contributor
-
Dumontier, Michel
SpringerLink (Online service)
- DOI
-
10.1186/s13326-016-0081-1
- URN
-
urn:nbn:de:1111-2016060915365
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Leung, Tiffany I.
- Dumontier, Michel
- SpringerLink (Online service)
Other Objects (12)
Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information
Analysis and identification of drug similarity through drug side effects and indications data
Label Free Spectromicroscopy on Drug and Drug Loaded Nanocarriers in Skin
Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks
InContext: curation of medical context for drug indications
Drug related problems and off-label drug treatment in children as seen at a drug information centre
The basics of preclinical drug development for neurodegenerative disease indications
Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships
Hierarchical structured materials for controlled oral drug delivery
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Off-label drugs use in pediatric palliative care
Screening lifespan-extending drugs in Caenorhabditis elegans via label propagation on drug-protein networks
Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information
Analysis and identification of drug similarity through drug side effects and indications data
Label Free Spectromicroscopy on Drug and Drug Loaded Nanocarriers in Skin
Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks
InContext: curation of medical context for drug indications
Drug related problems and off-label drug treatment in children as seen at a drug information centre
The basics of preclinical drug development for neurodegenerative disease indications
Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships
Hierarchical structured materials for controlled oral drug delivery
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Off-label drugs use in pediatric palliative care
Screening lifespan-extending drugs in Caenorhabditis elegans via label propagation on drug-protein networks
Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information
Analysis and identification of drug similarity through drug side effects and indications data
Label Free Spectromicroscopy on Drug and Drug Loaded Nanocarriers in Skin
Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks
InContext: curation of medical context for drug indications
Drug related problems and off-label drug treatment in children as seen at a drug information centre
The basics of preclinical drug development for neurodegenerative disease indications
Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships
Hierarchical structured materials for controlled oral drug delivery
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib
Off-label drugs use in pediatric palliative care